TR200003325T2 - Dopamin reseptörleri olarak yararlı fenilsülfonamit-feniletilaminler. - Google Patents

Dopamin reseptörleri olarak yararlı fenilsülfonamit-feniletilaminler.

Info

Publication number
TR200003325T2
TR200003325T2 TR2000/03325T TR200003325T TR200003325T2 TR 200003325 T2 TR200003325 T2 TR 200003325T2 TR 2000/03325 T TR2000/03325 T TR 2000/03325T TR 200003325 T TR200003325 T TR 200003325T TR 200003325 T2 TR200003325 T2 TR 200003325T2
Authority
TR
Turkey
Prior art keywords
phenylethylamines
phenylsulfonamide
useful
dopamine receptors
c3alkyl
Prior art date
Application number
TR2000/03325T
Other languages
English (en)
Turkish (tr)
Inventor
Glenn Romero Arthur
A. Leiby Jeffrey
Original Assignee
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company
Publication of TR200003325T2 publication Critical patent/TR200003325T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46Y being a hydrogen or a carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2000/03325T 1998-05-14 1999-05-07 Dopamin reseptörleri olarak yararlı fenilsülfonamit-feniletilaminler. TR200003325T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8549398P 1998-05-14 1998-05-14

Publications (1)

Publication Number Publication Date
TR200003325T2 true TR200003325T2 (tr) 2001-04-20

Family

ID=22191975

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03325T TR200003325T2 (tr) 1998-05-14 1999-05-07 Dopamin reseptörleri olarak yararlı fenilsülfonamit-feniletilaminler.

Country Status (24)

Country Link
US (1) US6103766A (enExample)
EP (1) EP1077935B1 (enExample)
JP (1) JP2002514623A (enExample)
KR (1) KR20010043546A (enExample)
CN (1) CN1152857C (enExample)
AT (1) ATE253045T1 (enExample)
AU (1) AU752543B2 (enExample)
BR (1) BR9910405A (enExample)
CA (1) CA2327345A1 (enExample)
DE (1) DE69912419T2 (enExample)
DK (1) DK1077935T3 (enExample)
EA (1) EA002918B1 (enExample)
ES (1) ES2211078T3 (enExample)
HU (1) HUP0101746A3 (enExample)
IL (1) IL139263A0 (enExample)
NO (1) NO20005732D0 (enExample)
NZ (1) NZ508152A (enExample)
PL (1) PL343891A1 (enExample)
PT (1) PT1077935E (enExample)
SK (1) SK16242000A3 (enExample)
TR (1) TR200003325T2 (enExample)
TW (1) TW450954B (enExample)
WO (1) WO1999058499A1 (enExample)
ZA (1) ZA200005921B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69839305T2 (de) * 1997-02-27 2009-04-09 Takeda Pharmaceutical Co. Ltd. Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta
JP2005508852A (ja) * 2001-05-07 2005-04-07 スミスクライン・ビーチャム・コーポレイション スルホンアミド
JP2004535390A (ja) * 2001-05-07 2004-11-25 スミスクライン・ビーチャム・コーポレイション スルホンアミド
MX2007004358A (es) 2004-10-14 2007-07-17 Abbott Gmbh & Co Kg Compuestos de azabicicloheptilo adecuados para tratar trastornos que responden a la modulacion del receptor de dopamina d3.
EP2311803A1 (en) 2004-10-14 2011-04-20 Abbott GmbH & Co. KG Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
EP2371814A1 (en) 2004-10-14 2011-10-05 Abbott GmbH & Co. KG Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
US8383641B2 (en) 2006-04-14 2013-02-26 Abbott Gmbh & Co. Kg Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
CN101421243B (zh) * 2006-04-14 2012-05-30 艾博特股份有限两合公司 适用于治疗对多巴胺d3受体调节有反应的病症的芳氧基乙胺化合物
EP2029528A1 (en) 2006-04-19 2009-03-04 Abbott GmbH & Co. KG Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
EP2074110A1 (en) 2006-04-19 2009-07-01 Abbott GmbH & Co. KG Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
WO2008026046A1 (en) * 2006-08-30 2008-03-06 Pfizer Products Inc. Morpholine d3 dopamine antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574741A (en) * 1969-04-14 1971-04-13 Mead Johnson & Co Sulfonamidophenalkylamines
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
GB9402197D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Compounds
CN1088062C (zh) * 1994-11-23 2002-07-24 纽罗根公司 某些4-氨基甲基-2-取代的咪唑衍生物2-氨基甲基-4-取代的咪唑衍生物新的一族多巴胺受体亚型特异性配体
IL126747A0 (en) * 1996-05-11 1999-08-17 Smithkline Beecham Plc Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
JP4425992B2 (ja) * 1996-07-22 2010-03-03 サファイア セラピューティクス,インコーポレイティド 成長ホルモン放出特性を有する化合物
JPH1180156A (ja) * 1997-09-04 1999-03-26 Hokuriku Seiyaku Co Ltd 1−(置換アリール)アルキル−1h−イミダゾピリジン−4−アミン誘導体

Also Published As

Publication number Publication date
US6103766A (en) 2000-08-15
HUP0101746A3 (en) 2002-10-28
NO20005732L (no) 2000-11-13
DK1077935T3 (da) 2004-02-16
BR9910405A (pt) 2001-01-09
EP1077935B1 (en) 2003-10-29
CN1152857C (zh) 2004-06-09
KR20010043546A (ko) 2001-05-25
AU752543B2 (en) 2002-09-19
PL343891A1 (en) 2001-09-10
ZA200005921B (en) 2001-11-14
EP1077935A1 (en) 2001-02-28
TW450954B (en) 2001-08-21
EA002918B1 (ru) 2002-10-31
WO1999058499A1 (en) 1999-11-18
DE69912419D1 (de) 2003-12-04
CA2327345A1 (en) 1999-11-18
HUP0101746A2 (hu) 2002-03-28
PT1077935E (pt) 2004-03-31
ATE253045T1 (de) 2003-11-15
NO20005732D0 (no) 2000-11-13
ES2211078T3 (es) 2004-07-01
DE69912419T2 (de) 2004-07-22
SK16242000A3 (sk) 2001-06-11
AU3741899A (en) 1999-11-29
NZ508152A (en) 2003-03-28
HK1036049A1 (en) 2001-12-21
CN1297431A (zh) 2001-05-30
EA200001184A1 (ru) 2001-04-23
IL139263A0 (en) 2001-11-25
JP2002514623A (ja) 2002-05-21

Similar Documents

Publication Publication Date Title
NO985599D0 (no) Arylsubstituerte, sykliske aminer som selektive dopamin D3-ligander
TR200003325T2 (tr) Dopamin reseptörleri olarak yararlı fenilsülfonamit-feniletilaminler.
PT1204654E (pt) Benzofurilpiperazinas agonistas do receptor 5-ht2c da serotonina
TR200201004T2 (tr) Monoamin reuptake önleyicileri olarak biaril eter türevleri
BG105082A (en) 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists
ES2124167A1 (es) Nuevos derivados del bencimidazol con actividad antihistaminica.
ES2031513T3 (es) Quinazolindionas y piridopirimidinadionas.
NO973532L (no) 2-aminoindaner som selektive dopamin D3-ligander
CA2045955A1 (en) Indole derivatives
AP2002002664A0 (en) Cyclohexylamine derivative as subtype selective NMDA receptor antagonists.
ES2130135T3 (es) Nuevos compuestos heterociclicos de 6,7,8,9-tetrahidro-3h-benz(e)indol con actividad terapeutica sobre el sistema nervioso central.
DE60014339D1 (de) Aryl- und heteroaryl-kondensierte aminoalkyl-imidazol-derivate: selektive modulatoren der gabaa-rezeptoren
ES2128668T3 (es) Agonistas del receptor de 5-ht4.
ATE341538T1 (de) Benzimidazolonderivate mit affinität zu serotonin-und dopaminrezeptoren
NO950974L (no) Nye N,N,N',N'-tetrasubstituert-1,2-etandiaminderivatforbindelser
ATE243695T1 (de) 5-bicycloindolverbindungen
BR8001019U (pt) Comedouro tubular de bacia para perus